Article
CRISPR/Cpf1 mediated genome editing enhances Bombyx mori resistance to BmNPV
medRxiv · 2020 · Dong, Z.; Qin, Q.; Hu, Z.; Zhang, X.; Miao, J.; Huang, L.; Chen, P.; Lu, C.; Pan, M.
Key facts
| Title | CRISPR/Cpf1 mediated genome editing enhances Bombyx mori resistance to BmNPV |
|---|---|
| First author | Dong, Z.; Qin, Q.; Hu, Z.; Zhang, X.; Miao, J.; Huang, L.; Chen, P.; Lu, C.; Pan, M. |
| Journal | medRxiv |
| Published | Mar 23, 2020 |
| DOI | 10.1101/2020.03.23.003368 |
| Devices mentioned | BK110039, DEN000008, K022086 |
| Product codes mentioned | JCI, KIT, NDS, NJT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1